HLA-DQB1 subtypes predict diabetic retinopathy in patients with type I diabetes mellitus

European Journal of Ophthalmology

Volumn 19, Issue 4, 2009, Pages 638-645

  Khazaee, Mohammad H ^a   Afshari, Jalil Tavakol ^b   Khazaee, Bahram ^b   Daneshvar, Ramin ^c,e   Akbarzadeh, Javad ^b   Khazaee, Ladan ^d   Ganjali, Rashin ^b   Raygan, Firoozeh ^d  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetic retinopathy; HLA DQB1 subtypes; Type I diabetes mellitus

Indexed keywords

HLA DQB1 ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; FEMALE; GENETIC PREDISPOSITION; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; GENE FREQUENCY; HAPLOTYPES; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES;

EID: 70549114871     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210901900419     Document Type: Article

References (30)

1. Taylor HR, Keeffe JE. World blindness: a 21st century perspective. Br J Ophthalmol 2001; 85: 261-6.
2. Chew EY, Ferris FL. Nonproliferative diabetic retinopathy. In: Ryan SJ. Retina. Philadelphia; Elsevier Mosby, 2006; 1271-84.
3. Radha V, Rema M, Mohan V. Genes and diabetic retinopathy. Ind J Ophthalmol 2002; 50: 5-11.
4. Frank RN. Etiologic mechanisms in diabetic retinopathy. In: Ryan SJ. Retina. Philadelphia: Elsevier Mosby, 2006; 1241-70.
5. Ferris FL III. How effective are treatments for diabetic retinopathy? JAMA 1993; 269: 1290-1.
6. Cahill GF Jr, Etzwiler LD, Freinkel N. Editorial: "Control" and diabetes. N Engl J Med 1976; 294: 1004-5.
7. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
8. Porta M, Sjoelie AK, Chaturvedi N, et al. Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study. Diabetologia 2001; 44: 2203-9.
9. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998; 105: 1801-15.
10. Rand LI, Krolewski AS, Aiello LM, Warram JH, Baker RS, Maki T. Multiple factors in the prediction of risk of proliferative diabetic retinopathy. N Engl J Med 1985; 313: 1433-8.
11. The Diabetes Control and Complications Trial Research Group. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes 1997; 46: 1829-39.
12. Zhang L, Krzentowski G, Albert A, Lefebvre PJ. Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 2001; 24: 1275-9.
13. Pyke DA, Tattersall RB. Diabetic retinopathy in identical twins. Diabetes 1973; 22: 613-8.
14. Alcolado J. Genetics of diabetic complications. Lancet 1998; 351: 230-1.
15. Graham DE. The isolation of high molecular weight DNA from whole organisms or large tissue masses. Anal Biochem 1978; 85: 609-13.
16. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
17. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-35.
18. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993; 41: 119-34.
19. Haider MZ, Shaltout A, Alsaeid K, Qabazard M, Dorman J. Prevalence of human leukocyte antigen DQA1 and DQB1 alleles in Kuwaiti Arab children with type 1 diabetes mellitus. Clin Genet 1999; 56: 450-6.
20. Kelly MA, Alvi NS, Croft NJ, Mijovic CH, Bottazzo GF, Barnett AH. Genetic and immunological characteristics of Type I diabetes mellitus in an Indo-Aryan population. Diabetologia 2000; 43: 450-6.
21. Chuang LM, Wu HP, Tsai WY, Lin BJ, Tai TY. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families. Diabetes Care 1995; 18: 1483-6.
22. Ikegami H, Kawaguchi Y, Yamato E, et al. Analysis by the polymerase chain reaction of histocompatibility leucocyte antigen-DR9-linked susceptibility to insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1992; 75: 1381-5.
23. Park YS, Wang CY, Ko KW, et al. Combinations of HLA DR and DQ molecules determine the susceptibility to insulin-dependent diabetes mellitus in Koreans. Hum Immunol 1998; 59: 794-801.
24. Mimura T, Funatsu H, Uchigata Y, et al. Relationship between human leukocyte antigen status and proliferative diabetic retinopathy in patients with younger-onset type 1 diabetes mellitus. Am J Ophthalmol 2003; 135: 844-8.
25. Mimura T, Funatsu H, Uchigata Y, et al. Glutamic acid decarboxylase autoantibody prevalence and association with HLA genotype in patients with younger-onset type 1 diabetes and proliferative diabetic retinopathy. Ophthalmology 2005; 112: 1904-9.
26. Agardh E, Gaur LK, Lernmark A, Agardh CD. HLA-DRB1, -DQA1, and -DQB1 subtypes or ACE gene polymorphisms do not seem to be risk markers for severe retinopathy in younger Type 1 diabetic patients. J Diabetes Complications 2004; 18: 32-6.
27. Agardh D, Gaur LK, Agardh E, Landin-Olsson M, Agardh CD, Lernmark A. HLA-DQB1*0201/0302 is associated with severe retinopathy in patients with IDDM. Diabetologia 1996; 39: 1313-7.
28. Cisse A, Chevenne D, Chauffert M, Ndiaye MR, Wade A, Trivin F. [HLA-markers and diabetic retinopathy in the Senegalese population.] Dakar Med. 1998; 43: 29-33.
29. Wong TY, Cruickshanks KJ, Klein R, et al. HLA-DR3 and DR4 and their relation to the incidence and progression of diabetic retinopathy. Ophthalmology 2002; 109: 275-81.
30. Amirzargar A, Mostafavi H, Farjadian S, Ghaderi A. Association of HLA-class II alleles and susceptibility to type 1 diabetes in Southern Iranian patients. Iranian J Med Sci 2000; 25: 109-13.